Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT03364569
Usefullness of Peri-operative Tranexamic Acid in Primary Breast Augmentation With Implants.
Sponsor: Hôpital NOVO
View on ClinicalTrials.gov
Summary
Tranexamic acid (TXA), as an antifibrinolytic agent, has shown a tremendous interest in surgery by reducing blood loss ; but only few articles have been reported in the plastic surgery scope. The aim of this study was to investigate whether oral administration of TXA reduces surgical drainage in primary breast augmentation using implants.
Key Details
Gender
FEMALE
Age Range
18 Years - 50 Years
Study Type
OBSERVATIONAL
Enrollment
40
Start Date
2014-11-01
Completion Date
2016-04-01
Last Updated
2026-06-09
Healthy Volunteers
No
Conditions
Interventions
PROCEDURE
Tranexamic acid
Participants with taking tranexamic acid (2 x 1g per day) as a preventive and without adjuvant treatment.
Locations (1)
Hôpital NOVO
Cergy-Pontoise, France